Alzheimer's Disease - Nursing Case Study

Pathophysiology

• Primary mechanism: Accumulation of beta-amyloid plaques disrupts neuronal communication and triggers inflammatory responses, leading to neuronal injury and death. This process compromises synaptic function and contributes to cognitive decline.

• Secondary mechanism: Tau protein hyperphosphorylation results in the formation of neurofibrillary tangles, which destabilize microtubule structures essential for intracellular transport. This disruption exacerbates neuronal dysfunction and accelerates brain atrophy.

• Key complication: Progressive loss of neurons and synapses in critical brain regions, such as the hippocampus and cortex, manifests as severe cognitive impairment, memory loss, and functional decline, severely affecting patients' quality of life and daily functioning.

Patient Profile

Demographics:

79-year-old male, retired aerospace engineer

History:

• Key past medical history: Alzheimer's disease diagnosed 8 years ago, hypertension, type 2 diabetes, chronic kidney disease stage 3

• Current medications: Donepezil, Memantine, Lisinopril, Metformin, Amlodipine, Insulin glargine

• Allergies: Penicillin

Current Presentation:

• Chief complaint: Progressive memory loss and confusion

• Key symptoms: Severe cognitive decline, agitation, hallucinations, incontinence, difficulty swallowing, recent falls

• Vital signs: Blood pressure 160/95 mmHg, heart rate 102 bpm, respiratory rate 24 breaths per minute, temperature 101.3°F, oxygen saturation 86% on room air

Section 1

New Complications:

In the weeks following the initial presentation, the patient, Mr. Thompson, began to experience significant deterioration in his functional status, prompting further evaluation. His family reported increased frequency of falls despite home safety modifications, alongside heightened agitation and resistance to care. Upon physical examination, Mr. Thompson exhibited marked muscle weakness and significant weight loss, suggesting possible malnutrition. He also demonstrated a noticeable decrease in verbal communication, relying more on non-verbal cues. His blood pressure remained elevated at 165/98 mmHg, and his heart rate had increased to 108 bpm, indicating potential autonomic dysregulation.

A thorough laboratory workup revealed worsening kidney function, with an eGFR dropping to 28 mL/min/1.73m², indicating progression to stage 4 chronic kidney disease. Serum electrolytes showed hyponatremia at 128 mEq/L and hyperkalemia at 5.8 mEq/L, raising concerns for potential cardiac arrhythmias. Mr. Thompson's glucose levels were poorly controlled, with a recent HbA1c of 9.2%, further complicating his metabolic state. In addition, a chest X-ray and arterial blood gas analysis were conducted due to persistent hypoxia, revealing bilateral lower lobe infiltrates suggestive of aspiration pneumonia, a potential consequence of his impaired swallowing function and frequent episodes of coughing during meals.

These new complications necessitate immediate and comprehensive intervention strategies, including adjustments to his medication regimen to manage kidney function and electrolyte imbalances, possible initiation of enteral feeding to address nutritional deficits, and aggressive treatment of his pneumonia. This evolving clinical scenario challenges the healthcare team to reassess Mr. Thompson's care plan, considering his complex medical needs and the multifaceted nature of his Alzheimer's progression. The team must employ advanced critical thinking to prioritize interventions that will optimize his quality of life while mitigating risks associated with his declining physiological status.

Section 2

New Complications:

Despite initial interventions, Mr. Thompson's condition continued to decline, presenting new challenges for the healthcare team. He developed severe edema in his lower extremities, with pitting noted upon examination, suggesting worsening heart failure potentially exacerbated by fluid retention and hypertension. His respiratory status also deteriorated, with increased work of breathing and an oxygen saturation consistently hovering around 88% on room air. Repeat arterial blood gas analysis indicated a respiratory acidosis with a pH of 7.30 and a PaCO2 of 50 mmHg, necessitating consideration for non-invasive ventilation support.

Further complicating his management, Mr. Thompson's neurological status evolved, with episodes of acute confusion and disorientation, possibly indicative of delirium superimposed on his Alzheimer's. This cognitive fluctuation posed significant challenges in establishing effective communication and cooperation during care activities. The healthcare team needed to explore potential causes, such as medication side effects, infections, or metabolic disturbances, and adjust his regimen accordingly.

Amid these developments, Mr. Thompson's family expressed growing concern about his quality of life and the burden of care. They requested a family meeting to discuss long-term care options and potential transitions, highlighting the need for a multidisciplinary approach to support both Mr. Thompson and his caregivers. The team, therefore, needed to engage in sensitive, holistic discussions that balanced medical complexity with the patient's and family's preferences, introducing palliative care considerations and advanced care planning as part of his evolving treatment strategy.

Section 3

The healthcare team conducted a comprehensive assessment to address Mr. Thompson's rapidly evolving condition. Notably, his vital signs revealed hypotension with a blood pressure of 90/60 mmHg and tachycardia at 110 beats per minute, suggesting potential cardiogenic shock secondary to his worsening heart failure. His heart sounds were muffled, and jugular venous distention was observed, raising concerns for possible cardiac tamponade. Peripheral pulses were weak and thready, and his skin was cool and clammy, indicating poor perfusion. In response to his respiratory deterioration, Mr. Thompson was placed on a BiPAP machine, which improved his oxygen saturation to 92%, but he continued to exhibit labored breathing and use of accessory muscles.

The team also reviewed Mr. Thompson's medication regimen, suspecting that polypharmacy could be contributing to his cognitive changes and delirium. A potential culprit was identified in the form of a newly prescribed anticholinergic medication for urinary incontinence, which was promptly discontinued. Laboratory tests were ordered to rule out infections and metabolic imbalances, with results showing a mild leukocytosis at 12,000/mm³ and elevated serum creatinine of 2.2 mg/dL, indicating possible acute kidney injury. His electrolyte panel revealed hyponatremia with a sodium level of 128 mEq/L, necessitating careful fluid management to address both his heart failure and renal function.

As these new complications unfolded, the healthcare team's focus shifted towards stabilizing Mr. Thompson's cardiovascular and respiratory status while simultaneously addressing his cognitive and renal challenges. The interdisciplinary team, including cardiology, nephrology, and geriatric specialists, convened to re-evaluate his treatment plan. Discussions emphasized the importance of balancing aggressive interventions with Mr. Thompson’s and his family's wishes for quality of life. This set the stage for an urgent family meeting to discuss the potential benefits and risks of advanced interventions, hospice care options, and the initiation of a tailored palliative care plan.

Section 4

As the healthcare team continued to monitor Mr. Thompson's condition, the focus was placed on his response to the recent interventions. Despite the discontinuation of the anticholinergic medication, Mr. Thompson's cognitive status showed minimal improvement. He remained disoriented, with episodes of agitation and confusion, raising concerns about underlying delirium due to his acute medical conditions. His cardiovascular status was tenuous, with persistent hypotension despite cautious fluid resuscitation efforts. The team initiated a low-dose norepinephrine infusion to support his blood pressure, carefully titrating to maintain a mean arterial pressure (MAP) above 65 mmHg.

Respiratory-wise, Mr. Thompson's work of breathing remained significant, with continued reliance on BiPAP support. His oxygen saturation held steady at 92% on the machine, but intermittent apneas were noted, suggesting potential central causes. This prompted a neurology consult to assess for any acute neurological events. Furthermore, his recent laboratory results indicated a worsening of renal function, with serum creatinine climbing to 2.8 mg/dL, suggesting progression of acute kidney injury. Electrolyte imbalances persisted, with sodium levels dropping further to 125 mEq/L, necessitating the delicate adjustment of intravenous fluids to prevent further deterioration.

Given these developments, the team faced the challenge of balancing the necessity of life-sustaining interventions with the potential for further complicating Mr. Thompson's fragile state. A comprehensive review of all medications was again undertaken to minimize polypharmacy risks. Additionally, the possibility of dialysis was discussed with the nephrology team, though it was acknowledged that Mr. Thompson's overall prognosis remained poor. The family was updated on his critical condition, and their input was sought to align future care decisions with Mr. Thompson's values and goals, emphasizing the importance of quality of life considerations. This set the stage for a pivotal decision-making point, where the continuation of aggressive treatment would need to be weighed against the initiation of comfort-focused care.

Section 5

As the night progressed, Mr. Thompson's condition took a concerning turn, manifesting new complications that demanded immediate attention. His cardiovascular status remained precarious despite the norepinephrine infusion, as his blood pressure fluctuated wildly, with systolic readings occasionally dipping below 80 mmHg. This instability was compounded by an episode of acute chest discomfort, raising suspicion of myocardial ischemia. An urgent electrocardiogram (ECG) revealed ST-segment depression in the anterior leads, indicative of a non-ST elevation myocardial infarction (NSTEMI). Cardiac enzymes were drawn, showing a troponin level of 0.12 ng/mL, which, although modestly elevated, warranted cautious consideration given his fragile state.

Simultaneously, neurological assessment revealed a subtle yet definite decline. Mr. Thompson exhibited profound lethargy, with a Glasgow Coma Scale (GCS) score dropping to 10. Neurological reflexes were sluggish, and his pupils appeared slightly anisocoric, suggesting possible increased intracranial pressure or further neurological insult. The neurology team recommended an urgent CT scan of the brain to rule out acute cerebrovascular events or other intracranial pathology. However, this presented a logistical challenge, requiring meticulous planning to safely transport Mr. Thompson while ensuring continued hemodynamic support and respiratory stability.

In the midst of these developments, Mr. Thompson's renal function continued to deteriorate, with serum creatinine climbing to 3.2 mg/dL, and potassium levels rising to 5.8 mEq/L, placing him at risk for life-threatening hyperkalemia. The nephrology team was re-engaged, and emergent dialysis was reconsidered as his electrolyte imbalances became increasingly refractory to medical management. The healthcare team faced the daunting task of integrating these new findings into an already complex clinical picture, necessitating a re-evaluation of therapeutic goals with an emphasis on interdisciplinary collaboration and sensitive communication with Mr. Thompson's family regarding the potential shift towards palliative care options.